Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0LB9U
|
|||
| Former ID |
DNC004410
|
|||
| Drug Name |
3-(2-Nitro-ethyl)-[1,4]oxazepan-(5Z)-ylideneamine
|
|||
| Synonyms |
CHEMBL314727; 3-(2-Nitro-ethyl)-[1,4]oxazepan-(5Z)-ylideneamine; SCHEMBL8550044; BDBM50104648
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C7H13N3O3
|
|||
| Canonical SMILES |
C1COCC(N=C1N)CC[N+](=O)[O-]
|
|||
| InChI |
1S/C7H13N3O3/c8-7-2-4-13-5-6(9-7)1-3-10(11)12/h6H,1-5H2,(H2,8,9)
|
|||
| InChIKey |
BWBBVEBIAZILKQ-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Selective heterocyclic amidine inhibitors of human inducible nitric oxide synthase. Bioorg Med Chem Lett. 2001 Oct 8;11(19):2651-3. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.